There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.
第一作者:
Michael E,Makover
第一单位:
New York University Grossman School of Medicine, New York, NY, USA.
作者:
关键词
ASCVD, Atherosclerotic cardiovascular diseaseAtherosclerosisCAC, Coronary artery calciumCAD, coronary artery diseaseCCTA, Coronary computed tomographic angiographyCHD, Coronary Heart DiseaseCholesterolCoronary artery diseaseDementiaFCT, Fibrous Cap ThicknessFH, Familial hypercholesterolemiaHDL-C, High-density lipoprotein cholesterolHMG CoA, 3-hydroxymethyl-3-methylglutaryl coenzyme AIDL, Intermediate-density lipoproteinLCBI, Lipid core burden indexLDL-C, low-density lipoprotein cholesterolLLT, Lipid-lowering therapyLipoproteinsMCI, Mild cognitive impairmentMI, myocardial infarctionMyocardial infarctionNFT, Neurofibrillary tangleNMR, Nuclear Magnetic ResonanceNPV, Negative predictive valuePAD, Peripheral Arterial DiseasePAV, Percent Atheroma VolumePCSK9, Proprotein convertase subtilisin:kexin type 9PreventionRCT, Randomized controlled trialStrokeVLDL, Very low-density lipoproteinapoB, apolipoprotein B
DOI
10.1016/j.ajpc.2022.100371
PMID
36124049
发布时间
2022-09-21
- 浏览3
American journal of preventive cardiology
2022年12卷
100371页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



